Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

× No keyword cloud information.

73 in total

1. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.

Authors: R C Cuneo; E A Espiner; M G Nicholls; T G Yandle; J H Livesey
Journal: J Clin Endocrinol Metab Date: 1987-10 Impact factor: 5.958

2. Physiological role of silent receptors of atrial natriuretic factor.

Authors: T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal: Science Date: 1987-10-30 Impact factor: 47.728

3. The reduction of renin and aldosterone as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides.

Authors: J P Stasch; C Hirth; S Kazda; D Neuser
Journal: Life Sci Date: 1988 Impact factor: 5.037

4. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

Authors: K J Koller; D G Lowe; G L Bennett; N Minamino; K Kangawa; H Matsuo; D V Goeddel
Journal: Science Date: 1991-04-05 Impact factor: 47.728

5. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

Authors: L Cao; D G Gardner
Journal: Hypertension Date: 1995-02 Impact factor: 10.190

6. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.

Authors: R I Cargill; A D Struthers; B J Lipworth
Journal: Clin Sci (Lond) Date: 1995-01 Impact factor: 6.124

7. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.

Authors: B Favrat; M Burnier; J Nussberger; J M Lecomte; R Brouard; B Waeber; H R Brunner
Journal: J Hypertens Date: 1995-07 Impact factor: 4.844

8. Role of atrial natriuretic polypeptides for exaggerated natriuresis in essential hypertension.

Authors: H Matsubara; Y Umeda; Y Yamane; M Nishikawa; T Taniguchi; M Inada
Journal: Am J Cardiol Date: 1987-09-15 Impact factor: 2.778

9. ANF and angiotensin II interact via kinases in the proximal straight tubule.

Authors: N H Garcia; J L Garvin
Journal: Am J Physiol Date: 1995-04

10. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.

Authors: B M Cheung; M J Brown
Journal: J Hypertens Date: 1994-04 Impact factor: 4.844

5 in total

1. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors: Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal: Hypertension Date: 2014-11-03 Impact factor: 10.190

Review 2. Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Authors: Dan Li; David J Paterson
Journal: J Physiol Date: 2016-05-05 Impact factor: 5.182

Review 3. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

Authors: Alessia Buglioni; John C Burnett
Journal: Clin Chim Acta Date: 2014-10-23 Impact factor: 3.786

4. Prior fluid and electrolyte imbalance is associated with COVID-19 mortality.

Authors: Satu Nahkuri; Tim Becker; Vitalia Schueller; Steffen Massberg; Anna Bauer-Mehren
Journal: Commun Med (Lond) Date: 2021-11-25

5. ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.

Authors: Abdu Adem; Mahmoud Al Haj; Sheela Benedict; Javed Yasin; Nicolas Nagelkerke; Fred Nyberg; Tim G Yandle; Chris M Frampton; Lynley K Lewis; M Gary Nicholls; Elsadig Kazzam
Journal: PLoS One Date: 2013-03-13 Impact factor: 3.240

5 in total